GSI 704 (Truvada 133 mg / 200 mg)
Generic Name: emtricitabine/tenofovir
Pill with imprint GSI 704 is Blue, Rectangle and has been identified as Truvada 133 mg / 200 mg. It is supplied by Gilead Sciences, Inc.
Truvada is used in the treatment of pre-exposure prophylaxis; occupational exposure; nonoccupational exposure; hiv infection and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Truvada 133 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GSI 704
Truvada
- Generic Name
- emtricitabine/tenofovir
- Imprint
- GSI 704
- Strength
- 133 mg / 200 mg
- Color
- Blue
- Size
- 16.00 mm
- Shape
- Rectangle
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- National Drug Code (NDC)
- 61958-0704
- Inactive Ingredients
-
croscarmellose sodium,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
corn starch,
water,
FD&C Blue No. 2,
aluminum oxide,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
More about Truvada (emtricitabine / tenofovir)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (34)
- Drug images
- Compare alternatives
- Pricing & coupons
- Generic availability
- En español
- Drug class: antiviral combinations
- FDA approval history
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.